COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,031 Articles (22,627 medRxiv, 8,404 bioRxiv)

Most recent first Previous |  Page 164: Articles 1631-1640  | Next

Brains Under Stress: Unravelling the Effects of the COVID-19 Pandemic on Brain Ageing
Mohammadi-Nejad, A.-R., Craig, M., Cox, E., Chen, X., Jenkins, R. G., Francis, S., Sotiropoulos, S., Auer, D. P.
10.1101/2024.07.22.24310790 — Posted: 2024-07-22
Analysis of B-cell receptor repertoire to evaluate the immunogenicity of SARS-CoV-2 RBD mRNA vaccine: MAFB-7256a (DS-5760d)
Ohji, G., Funakoshi, Y., Yakushijin, K., Matsutani, T., Sasaki, T., Kusakabe, T., Matsumoto, S., Koyama, T., Nagatani, Y., Kurata, K., Kimbara, S., Kiyota, N., Minami, H.
10.1101/2024.07.19.24310697 — Posted: 2024-07-21
Biguanides Associate with Decreased Early Mortality and Risk of Acute Kidney Injury In Hospitalized COVID-19 Patients: a nationwide retrospective cohort study in Japan
Sugimoto, M., Kikuchi, H., Sohara, E., Limbutara, K., Hirakawa, A., Mori, T., Susa, K., Oya, S., Suzuki, T., Iimori, S., Fushimi, K., Uchida, S.
10.1101/2024.07.20.24310736 — Posted: 2024-07-21
Rapid Detection of Active Coronavirus Infection by Lateral Flow Test Strips: A New Approach to Distinguish Replicating Viruses from Non-Replicating Viruses
Davis, D., Lamb, C. H., Myhrvold, C. A., Ullah, H.
10.1101/2024.07.18.604218 — Posted: 2024-07-19
SARS-CoV-2 B Epitope-Guided Neoantigen NanoVaccines Enhance Tumor-Specific CD4/CD8 T Cell Immunity Through B Cell Antigen Presentation
Li, C., Mao, S., Montemayor, Z., Traore, M. D. M., Duran, A., Ke, F., Djibo, M., Wen, H., Gao, W., Sun, D.
10.1101/2024.07.18.604163 — Posted: 2024-07-19
Early evolution of the BA.2.86 variant sheds light on the origins of highly divergent SARS-CoV-2 lineages
Escalera Zamudio, M., Tan, C., van Dorp, L., Balloux, F.
10.1101/2024.07.18.604213 — Posted: 2024-07-19
Vaccine-related misinformation and attitude toward COVID-19 vaccination in Japan
Furuse, Y., Tabuchi, T.
10.1101/2024.07.17.24310600 — Posted: 2024-07-18
Spatial and temporal transmission dynamics of respiratory syncytial virus in New Zealand before and after the COVID-19 pandemic
Jelley, L., Douglas, J., O'Neill, M., Berquist, K., Classen, A., Wang, J., Utekar, S., Johnston, H., Bocacao, J., Allais, M., de Ligt, J., Tan, C. E., Seeds, R., Wood, T., Aminisani, N., Jennings, T., Welch, D., Turner, N., McIntyre, P., Dowell, T., Trenholme, A., Byrnes, C., The SHIVERS Investigation Team, , Webby, R., French, N., Winter, D., Huang, Q. S., Geoghegan, J. L.
10.1101/2024.07.15.24310412 — Posted: 2024-07-17
Evolution of SARS-CoV-2 spike trimers towards optimized heparan sulfate cross-linking and inter-chain mobility
Froese, J., Mandalari, M., Civera, M., Elli, S., Pagani, I., Vicenzi, E., Garcia-Monge, I., Di Iorio, D., Frank, S., Bisio, A., Lenhart, D., Gruber, R., Yates, E. A., Richter, R. P., Guerrini, M., Wegner, S. V., Grobe, K.
10.1101/2024.07.17.603909 — Posted: 2024-07-17
Virological characteristics of the SARS-CoV-2 KP.3.1.1 variant
Kaku, Y., Uriu, K., Okumura, K., The Genotype to Phenotype Japan (G2P-Japan) Consortium, , Ito, J., Sato, K.
10.1101/2024.07.16.603835 — Posted: 2024-07-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).